Freshpet (FRPT) director receives 1,589 restricted shares vesting in 2027

Rhea-AI Filing Summary

Fajemirokun-Beck Olufunlayo Olurinde reported acquisition or exercise transactions in this Form 4 filing.

Freshpet, Inc. director Fajemirokun-Beck Olufunlayo Olurinde received a grant of 1,589 shares of restricted common stock as compensation. These shares were awarded under the company’s 2024 Equity Incentive Plan and will vest on March 15, 2027, if she remains on the Board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fajemirokun-Beck Olufunlayo Olurinde

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		1,589(1)	A	$0	11,204	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

	/s/ Lisa A. Alexander, as Attorney-in-Fact for the Reporting Person	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Freshpet (FRPT) report for Fajemirokun-Beck Olufunlayo Olurinde?

Freshpet reported that director Fajemirokun-Beck Olufunlayo Olurinde received 1,589 shares of restricted common stock. The award was granted at no cash cost under the 2024 Equity Incentive Plan as part of her director compensation package.

How many Freshpet (FRPT) shares does the director hold after this Form 4 grant?

After the grant, Fajemirokun-Beck Olufunlayo Olurinde directly holds 11,204 shares of Freshpet common stock. This figure includes the newly awarded 1,589 restricted shares, which are subject to vesting conditions tied to continued Board service.

When do the newly granted Freshpet (FRPT) restricted shares vest?

The 1,589 shares of restricted Freshpet common stock vest on March 15, 2027. Vesting is contingent on Fajemirokun-Beck Olufunlayo Olurinde’s continued service on the company’s Board of Directors through that date under the 2024 Equity Incentive Plan.

What type of transaction is reported in this Freshpet (FRPT) Form 4?

The Form 4 reports an acquisition coded “A,” reflecting a grant or award of common stock. It is a non-derivative equity award, not an open-market purchase or sale, and is part of the director’s equity-based compensation structure.

Was there any cash paid for the Freshpet (FRPT) restricted stock grant?

No cash was paid for the grant; the transaction price per share is reported as 0.0000. The 1,589 restricted shares represent a stock-based compensation award provided under Freshpet’s 2024 Equity Incentive Plan for Board service.